
Sotera Health Company: updates and filings
Price
$16.16
November 19, 2026Market cap $4.6B
What Ploutos Investor adds for Sotera Health
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 3, 2026next Feb 4, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
May 2026
- 22FriShareholdersShareholder voteDocument
- 20WedDealMaterial agreement entered, new material financial obligationDocument
- 13WedDealMaterial agreement ended, other material eventsDocument
- 5TueReportQuarterly report · for the period to Mar 31, 2026Document
- 5TueResultsResults of operations, officer or director changeDocument
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 3, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 3, 2026Results of operationsForm8-K
- Oct 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Oct 9, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 14, 2026Officer or director changeForm8-K
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operationsForm8-K
- Jul 30, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 29, 2026Conflict minerals reportFormSD
- May 22, 2026Shareholder voteForm8-K
- May 20, 2026Material agreement entered, new material financial obligationForm8-K
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 15, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- May 13, 2026Material agreement ended, other material eventsForm8-K
- May 5, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 5, 2026Additional annual meeting materialFormDEFA14A
- May 5, 2026Results of operations, officer or director changeForm8-K
- Apr 8, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 8, 2026Additional annual meeting materialFormDEFA14A
- Apr 8, 2026Annual meeting proxy statementFormDEF 14A
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 16, 2026Officer or director changeForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 3, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 3, 2026 | 8-K | Results of operations | Document |
| Oct 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Oct 9, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 14, 2026 | 8-K | Officer or director change | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations | Document |
| Jul 30, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 29, 2026 | SD | Conflict minerals report | Document |
| May 22, 2026 | 8-K | Shareholder vote | Document |
| May 20, 2026 | 8-K | Material agreement entered, new material financial obligation | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 15, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| May 13, 2026 | 8-K | Material agreement ended, other material events | Document |
| May 5, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 5, 2026 | DEFA14A | Additional annual meeting material | Document |
| May 5, 2026 | 8-K | Results of operations, officer or director change | Document |
| Apr 8, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 8, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 8, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 16, 2026 | 8-K | Officer or director change | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Sep 2, 2020.
The full analysis
What do Sotera Health's filings show?
The filings are where every one of Sotera Health's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.